Prothena reported 1.26B in Market Capitalization this June of 2022, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 3.91B 0.15B
Agios Pharmaceuticals AGIO:US $ 1.59B 0.19B
Akebia Therapeutics AKBA:US $ 0.13B 0.26B
ALKERMES ALKS:US 4.26B 0.49B
Alnylam Pharmaceuticals ALNY:US $ 19.71B 0.57B
Amgen AMGN:US $ 129.08B 2.36B
Biogen BIIB:US $ 30.95B 4.29B
Biomarin Pharmaceutical BMRN:US $ 14.26B 1.96B
Bluebird Bio BLUE:US $ 0.35B 0.35B
Exelixis EXEL:US $ 7.26B 1.48B
Intercept Pharmaceuticals ICPT:US $ 0.48B 0B
Intra Cellular Therapies ITCI:US $ 5.75B 1.49B
IONIS PHARMACEUT IONS:US $ 5.25B 0.95B
Macrogenics MGNX:US $ 0.54B 0.44B
Nektar Therapeutics NKTR:US $ 1B 1.49B
Neurocrine Biosciences NBIX:US $ 8.95B 0.87B
Prothena PRTA:US 1.71B 0.59B
Regeneron Pharmaceuticals REGN:US $ 75.81B 7.89B
Seattle Genetics SGEN:US $ 26.45B 1.82B
Ultragenyx Pharmaceutical RARE:US $ 5.04B 0.69B
Vertex Pharmaceuticals VRTX:US $ 66.69B 10.85B
Vital Therapies VTL:US $ 0.33B 0.08B
Xoma XOMA:US $ 0.32B 0.08B
YTE INCY:US $ 17.58B 1.36B